Articles
Volume 10 Supplement 2
Familial Aspects of Cancer 2011 Research and Practice
Meeting abstracts
Familial Aspects of Cancer 2011 Research and Practice: A combined meeting of kConFab, Australian Breast Cancer Family Study, Australian Colorectal Cancer Family Study, Australian Ovarian Cancer Study, Family Cancer Clinics of Australia and New Zealand and kConFab
Kingscliff, Australia
23-26 August 2011
Edited by Rodney Scott
|
Clinical management of women in BRCAX families: issues and controversies G Mitchell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A1 (12 April 2012) |
|
Polyposis syndromes– what to do when genotyping seems not informative F Macrae Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A2 (12 April 2012) |
|
Inherited and DM Thomas, ML Ballinger, International Sarcoma Kindred Study Consortium Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A3 (12 April 2012) |
|
A McEwen Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A4 (12 April 2012) |
|
B Meiser, MA Price, PN Butow, J Karatas, M Charles, KA Phillips, kConFab Psychosocial and Clinical Follow-Up groups, kConFab investigators Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A5 (12 April 2012) |
|
N Hallowell, L Heiniger, B Baylock, M Price, P Butow, kConFab Psychosocial Group, kConFab Investigators Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A6 (12 April 2012) |
|
Use of SDHB immunohistochemistry to identify germline mutations of SDH genes AJ Gill Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A7 (12 April 2012) |
|
Dissecting genetic pathways in schwannomatosis and malignant rhabdoid tumour E Algar Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A8 (12 April 2012) |
|
An update of clinical issues from InSIGHT 2011 L Lipton Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A9 (12 April 2012) |
|
Selecting women for breast cancer chemoprevention and what agents should be used J Cuzick Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A10 (12 April 2012) |
|
KA Phillips, RL Milne, MA Rookus, D Goldgar, M Friedlander, SA McLachlan, S Buys, AC Antoniou, K Birch, MB Terry, DF Easton, P Weideman, M Daly, N Andrieu, EM John, MJ Hooning, IL Andrulis, T Caldes, H Olsson, JL Hopper Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A11 (12 April 2012) |
|
Bowel cancer chemoprevention - ready for the clinic? J Burn Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A12 (12 April 2012) |
|
Risk-reducing surgery for breast and ovarian cancer risks - where are we now? N Hallowell, B Baylock, L Heiniger, M Price, P Butow Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A13 (12 April 2012) |
|
H Shipman, A Clarke Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A14 (12 April 2012) |
|
MA Young, S Wake, K Alsop, D Bowtell, G Mitchell, The Australian Ovarian Cancer Study Group, L Plunkett, A Crook, M Gleeson, N Hallowell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A15 (12 April 2012) |
|
Peer live supervision in the familial cancer setting M Kentwell, A Sexton, L Hodgkin, Y Bylstra, M Bogwitz, K Mann, J Taylor, M Sahhar, F Pearce, I Winship, GJ Lindeman Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A16 (12 April 2012) |
|
S Buscombe Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A17 (12 April 2012) |
|
L Schofield, F Grieu, J Goldblatt, B Amanuel, B Iacopetta Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A18 (12 April 2012) |
|
KS Boparai, E Dekker, CJM van Noesel Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A19 (12 April 2012) |
|
Serrated polyposis syndrome and colonoscopic surveillance: who is it safe to follow? S Parry, S Woodall, G Willdridge, MD Walsh, DD Buchanan, C Rosty, JP Young Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A20 (12 April 2012) |

